Methods for differentiating prion types in food-producing animals by Gough, Kevin C. et al.
Gough, Kevin C. and Rees, Helen C. and Ives, Sarah E. 
and Maddison, Ben C. (2015) Methods for differentiating 
prion types in food-producing animals. Biology, 4 (4). pp. 
785-813. ISSN 2079-7737 
Access from the University of Nottingham repository: 
http://eprints.nottingham.ac.uk/38512/1/Gough%20et%20al%20differentiating%20prion
%20types.pdf
Copyright and reuse: 
The Nottingham ePrints service makes this work by researchers of the University of 
Nottingham available open access under the following conditions.
This article is made available under the Creative Commons Attribution licence and may be 
reused according to the conditions of the licence.  For more details see: 
http://creativecommons.org/licenses/by/2.5/
A note on versions: 
The version presented here may differ from the published version or from the version of 
record. If you wish to cite this item you are advised to consult the publisher’s version. Please 
see the repository url above for details on accessing the published version and note that 
access may require a subscription.
For more information, please contact eprints@nottingham.ac.uk
Biology 2015, 4, 785-813; doi:10.3390/biology4040785 
 
biology 
ISSN 2079-7737 
www.mdpi.com/journal/biology 
Review 
Methods for Differentiating Prion Types in  
Food-Producing Animals  
Kevin C. Gough 1,*, Helen C. Rees 2, Sarah E. Ives 1 and Ben C. Maddison 2 
1 School of Veterinary Medicine and Science, The University of Nottingham, Sutton Bonington 
Campus, College Road, Sutton Bonington, Leicestershire LE12 5RD, UK;  
E-Mail: svysei@exmail.nottingham.ac.uk  
2 ADAS UK, School of Veterinary Medicine and Science, The University of Nottingham,  
Sutton Bonington Campus, College Road, Sutton Bonington, Leicestershire LE12 5RD, UK;  
E-Mails: Helen.Rees@adas.co.uk (H.C.R.); Ben.Maddison@adas.co.uk (B.C.M.) 
* Author to whom correspondence should be addressed; E-Mail: Kevin.Gough@nottingham.ac.uk;  
Tel.: +44-115-951-6272; Fax: +44-115-951-6440.  
Academic Editor: Christian D. Doerig 
Received: 31 August 2015 / Accepted: 4 November 2015 / Published: 13 November 2015 
 
Abstract: Prions are an enigma amongst infectious disease agents as they lack a genome 
yet confer specific pathologies thought to be dictated mainly, if not solely, by the 
conformation of the disease form of the prion protein (PrPSc). Prion diseases affect humans 
and animals, the latter including the food-producing ruminant species cattle, sheep, goats 
and deer. Importantly, it has been shown that the disease agent of bovine spongiform 
encephalopathy (BSE) is zoonotic, causing variant Creutzfeldt Jakob disease (vCJD) in 
humans. Current diagnostic tests can distinguish different prion types and in food-
producing animals these focus on the differentiation of BSE from the non-zoonotic agents. 
Whilst BSE cases are now rare, atypical forms of both scrapie and BSE have been 
reported, as well as two types of chronic wasting disease (CWD) in cervids. Typing of 
animal prion isolates remains an important aspect of prion diagnosis and is now becoming 
more focused on identifying the range of prion types that are present in food-producing 
animals and also developing tests that can screen for emerging, novel prion diseases. Here, 
we review prion typing methodologies in light of current and emerging prion types in  
food-producing animals. 
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1. Introduction 
1.1. Transmissible Spongiform Encephalopathies, and the Concept of Prions as an Infectious Agent 
The transmissible spongiform encephalopathies (TSEs), commonly referred to as prion diseases, are 
a group of infectious, fatal neurodegenerative disorders that affect a number of mammalian species, 
including man. The prion hypothesis proposes that the infectious agent is largely comprised of the 
PrPSc conformer of a benign host encoded membrane glycoprotein (PrPC) in the absence of any coding 
nucleic acid [1]. The conformational rearrangements (protein misfolding) that accompany conversion 
of PrPC to PrPSc result in increased insolubility in detergents [2] and protease resistance [3]. PrPC has a 
wide tissue distribution and is present as di-, mono- and un-glycosylated forms. It is thought that PrPSc 
is responsible for the conversion of additional molecules of PrPC into PrPSc and that this is the central 
molecular event that occurs during TSE disease. This conversion event is largely restricted to those 
cells of the lymphoreticular tissues (LRS) and central nervous system (CNS), and the end product has a 
propensity to aggregate and form amyloid. It is unclear as to the effect of the loss of function of PrPC 
that occurs after conversion to PrPSc as the physiological function of PrPC remains a controversial 
matter. However, it is thought that either this PrPSc end product, or a conformer of this protein formed 
along the folding pathway is toxic to cells of the CNS and is responsible for the characteristic brain 
pathology including the spongiosis, astrocytosis and neuronal loss that are commonly associated with 
these diseases. 
1.2. Examples of Prion Diseases  
Prion diseases occur in humans, for example Creutzfeldt-Jakob disease (CJD) and kuru. They also 
occur in food-producing animals (Table 1), namely the ruminant species sheep, goats, cattle and deer. 
Sheep and goats are susceptible to the prototypic prion disease, classical scrapie, as well as 
atypical/Nor98 scrapie, cattle and goats are susceptible to classical bovine spongiform encephalopathy 
(BSE) and cattle also to atypical BSE types L- and H-type, and cervids are affected by chronic wasting 
disease (CWD). Some prion diseases are inherited whilst others can be spontaneous or be acquired 
from an extraneous source. Prion diseases of ruminants are usually the latter, for example classical 
BSE infection of cattle arose from the consumption of BSE contaminated feed, and in sheep and goats 
classical scrapie may be transmitted via direct contact with infected animals or their environs. 
However, it has been suggested that atypical BSE and atypical/Nor98 scrapie diseases may occur 
spontaneously [4–7]. Prion diseases became the focus of intense research following the UK BSE 
epidemic in cattle in the late 1980s and 1990s, and then the identification of this as the causal agent of 
variant CJD (vCJD) in humans. The zoonotic potential of this class of disease causing agents along with 
the emergence of several newly recognised TSEs in recent years, notably atypical types of both scrapie 
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and BSE, illustrate the requirement for continued research and surveillance into TSEs of food-producing 
animals. This includes the development of methods for their detection and differentiation.  
Table 1. Prion types affecting farmed ruminants. 
Prion types * Host Species 
Classical BSE (bovine spongiform encephalopathy) Cattle, Goats # 
Atypical BSE: H-BSE, L-BSE/bovine amyloidotic spongiform 
encephalopathy (BASE) 
Cattle 
Classical Scrapie^ Sheep, Goats 
CH1641 Scrapie+ Sheep 
Atypical/Nor98 Scrapie Sheep, Goats 
CWD (chronic wasting disease) White-tailed deer, Elk, Mule Deer, Moose 
* Types as defined through analysis of tissue taken from food production animals. # BSE in goats is very rare, 
to date only 2 cases of BSE have been recorded in this species. ^ Further characterisation of classical scrapie 
isolates in inbred strains of mice have demonstrated that the classical scrapie category can comprise over 15 
distinct scrapie strains. + CH1641 scrapie is a rare form of scrapie found in sheep that shares similar 
biochemical features to that of BSE.  
1.3. TSE Diagnosis 
TSEs often present as a spectrum of different clinical signs in the infected animal. In  
scrapie-affected sheep and goats, infection may show as pruritus, weight loss, wool pulling, the 
swaying of hips and hind limbs, and animals can develop a body tremor and have an increased 
sensitivity to noise and movement. As disease progresses animals can develop an inability to stand, 
and exhibit other behavioural changes. In BSE affected cattle clinical observations may be subtle or 
obvious and can include changes in temperament such as nervousness or aggression, animals can also 
be seen to develop an abnormal posture, demonstrate a lack of coordination and have difficulty in 
rising. There is decreased milk production, and animals often show weight loss. With CWD, clinical 
signs may include emaciation, an excessive salivation, ataxia, the drooping of head and ears, weakness 
and behavioural changes.  
For all ruminant prion diseases, clinical signs are not specific enough for diagnosis and often these 
signs may be subtle or go unnoticed. The most common methods for diagnosing prion diseases rely on 
differentiating between PrPC and PrPSc in post mortem samples by their distinct resistances to 
proteinase K (PK): under defined conditions, PrPC is completely degraded and PrPSc is cleaved at the 
N-terminus leaving a protease resistant core of 27 to 30 kDa (Figure 1). PrPSc is so far the only 
validated marker for TSE infection. Post-mortem tissue is usually examined for the presence of PrPSc 
by either western blot or ELISA methods after PK treatment, or by immunohistochemical (IHC) 
staining techniques that define foci of PrPSc aggregation in the absence of protease treatment.  
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Figure 1. (A) Example western blot using a core antibody to detect prion protein (PrPSc) 
after proteinase K digestion showing the typical di- mono- and unglycosylated protein 
banding pattern. Ovine scrapie, ovine bovine spongiform encephalopathy (BSE) and 
bovine classical BSE (c-BSE) are shown, M, molecular mass markers 20 and 30kDa. 
Evident are the lower molecular weight of the unglycosylated protein band in ovine or 
bovine BSE compared to scrapie. Also, the di-glycan band is more dominant in BSE 
compared to the scrapie sample. A schematic diagram (B) to illustrate examples of the 
different electrophoretic glycoform profiles of the PrPSc from different prion types 
following Proteinase K digestion and western blotting using an antibody to the core region 
of the prion protein. Ovine SSBP1 is readily differentiated from both CH1641 scrapie and 
BSE, by glycoform ratio and molecular weight of the unglycosylated PrPSc species. 
Atypical forms of scrapie are less protease resistant than classical scrapie and typically 
show lower molecular weight species. The unglycosylated PrPSc band in classical bovine 
BSE is intermediate in size between that of L-type and H-type atypical forms of bovine 
BSE. M.W. Molecular mass markers in kDa. It should be noted that for ovine CH1641and 
bovine H-BSE, evidence for two different conformer populations are present within these 
profiles. These are revealed upon independently probing blots with the core antibody 
SAF84 and a second antibody that binds more towards the N terminus (for example L42), 
and evidenced by differences within the glycoprofiles and banding patterns between these 
blot [8,9], also see sections 4.1 and 4.2. This is a unique trait of these two prion types.  
1.4. The Concept of Prion Strains and Species Barrier 
Prion strains are defined TSE isolates that when transmitted to a specific host species (usually an 
inbred strain of mouse) exhibit phenotypic disease traits that are distinct from one another. These traits 
include differences in disease incubation time, the lesion profile and IHC staining pattern within the 
CNS, and the biochemical characteristics of the PrPSc [10]. A characteristic of prion strains is that 
these traits are stable over serial transmission within that same host species. The basis of TSE strains 
may be explained by the notion that PrPSc can adopt different conformations within the secondary, 
tertiary or quaternary structure of the protein. Experimental evidence illustrating that TSE strains are 
likely to be made up of different conformational forms of PrPSc has been repeatedly demonstrated by 
the different strain-to-strain properties of the PrPSc protein with regard to protease digestion with  
PK [11] and treatment with different chaotropic agents [12]. Within TSE surveillance the term strain 
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typing is often used to refer to the description of the biochemical properties of PrPSc from a particular 
isolate, however the true identification of a TSE strain can only be confirmed by determining a stable 
disease phenotype in specific lines of inbred rodent strains.  
The ability of a TSE to infect a distinct host species is governed by a phenomenon commonly 
referred to as the species barrier [13]. When prion-containing material is inoculated experimentally 
from one species into another, for example an isolate of sheep scrapie being inoculated into an inbred 
mouse line, the incubation time for the development of TSE will often be long and there will be an 
incomplete attack rate (only a proportion of the mice inoculated will develop disease). This inefficient 
transmission is the species barrier. However, if brain material from these infected animals from this 
first passage is then further inoculated into more animals of the same genetic background, the attack 
rate will increase and the incubation time to disease will reduce. On subsequent passage this incubation 
time will stabilise to produce consistent and reproducible incubation times, hit rates and other 
phenotypic properties. The apparent “species barrier” between the inoculum from the donor species 
and the recipient species will have been overcome. Species barriers can also be overcome where 
homologous PrPC is expressed in the host and the infecting inoculum, as is the case when using 
transgenic rodents for bioassay [14]. The nature of the TSE agent also contributes to the species 
barrier. An example is BSE, this TSE of cattle is experimentally transmissible to a wide variety of 
species with diverse PrPC primary structures [15] and in natural transmissions it has caused prion 
disease in a number of species including humans, domestic cats (FSE) and exotic ungulates [16], 
presumably as a result of ingestion of BSE-contaminated food. This is in contrast to scrapie, where a 
similar variety of species would have been exposed to the scrapie agent, yet this disease has only been 
seen in natural infections of sheep and goats. 
1.5. The Emergence of “New” Prion Strains 
Whilst it is easy to regard prion strains as a fixed entity, several lines of experimental evidence 
suggest that this is an oversimplification. ‘New’ strains with different properties to that in the inoculum 
have been seen to emerge after transmission to different species, even when the inoculum had been 
cloned by limiting dilution [17]. The emerging view is that a prion strain may exist much like a 
quasispecies for viral and bacterial pathogens. The cloud hypothesis [13] proposes that a wide range of 
PrPSc conformers are possible within a given strain, but that within each prion ‘strain’ only a subset of 
those conformers are able to interact with the host PrPC that is presented within any given infection. 
Thus there will be a range of PrPSc infectious conformers that are able to become the dominant species 
upon transmission within a new host. For an efficient infection to proceed the PrPC from the host has to 
be capable of forming a conformation that is compatible with the infecting PrPSc strain. Thus the 
selection of the new dominant species is dependent on the appropriate conditions being present for its 
selection. The selection of a minor conformer within a newly infected host and its preferential 
replication over the previous dominant ‘strain’ would go some way to explaining how prion strains can 
apparently mutate (Figure 2).  
A complementary theory has also been proposed called “the deformed template theory”, suggesting 
that the replication environment not only influences the evolution of existing PrPSc conformations to 
become the dominant strain, but actually plays an active and vital role to produce novel de novo PrPSc 
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conformations (Figure 2). It is likely that the cloud hypothesis and deformed template theory are both 
relevant, the main differences between the two theories are that in the deformed template theory the 
environment has an active part in the creation of novel PrPSc conformations and that the original or 
“parent” prions act as a template for the creation of such de novo prion strains [18].  
Studies have suggested that novel synthetic prions can be created de novo; a transmissible prion 
strain being generated after inoculation of rodents with recombinant-PrP amyloid fibrils. This could 
give further support to the deformed template theory with PrPSc possibly being formed from the 
original (non-PrPSc) fibrils [19–21]. Using an in vitro prion replication method (protein misfolding 
cyclic amplification; PMCA) to amplify prions from a scrapie-infected brain sample, another study 
showed that when RNA was removed from and then returned to the replication environment, a novel 
prion strain developed which was not present in the original brain sample, further supporting the 
deformed template theory [22]. 
 
Figure 2. (A) The premise of the “cloud” hypothesis is that a prion type is comprised of a 
heterogeneous mix of PrPSc variants made up of a dominant conformer (the example given 
is depicted in red) and minor populations of PrPSc variants (other colours). A change in the 
replication environment or an environmental pressure can then select for a minor variant 
within the “cloud” to become the dominant type over time (the example of a new dominant 
PrPSc conformer is depicted in green). (B) The deformed template theory proposes that new 
PrPSc structural variants are created directly from the original dominant conformer (blue) 
due to a new environment for replication. Variants are generated from a number of trial 
and error seeding events and one that is particularly suited to the new replication 
environment becomes the new dominant conformer (red) replacing the original variant 
(blue) (figure adapted from Makarava and Baskakov [18]). 
A 
 
 
 
 
 
 
 
B 
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1.6. The Significance of New Strain Emergence 
Prion strains can appear to undergo Darwinian selection given the right selective pressures. 
Ghaemmaghami and co-workers [23] have demonstrated the in vitro and in vivo selection of novel prions 
in both cell culture and in mice, using biologically cloned murine adapted prions. In these experiments 
prions could be seen to adapt to the selection pressures of either brain (infection of mice) or cell culture 
replication where the action of the anti-prion compound quinacrine could select for resistant prions. In 
addition, Li and co-workers [24] demonstrated that the rodent scrapie strain 22L changed its dominant 
conformer and concomitant disease phenotype due to selective pressure exerted by the presence of 
swainsonine which disrupts N-linked glycosylation. These observations support the notion of a prion 
quasispecies and prion strain selection; they are also extremely important to our understanding of these 
diseases and the potential zoonotic risk that these diseases may pose in the future.  
A recent study used transgenic mouse bioassay to examine a mixture of ovine scrapie isolates 
before and after incubation on soil for 13 months to determine whether the dominant types were 
consistent during this incubation period within an environmental matrix [25]. The data showed that 
prolonged ageing of scrapie prions within the soil resulted in changes in the dominant scrapie 
pathologies and concomitant PrPSc biological/biochemical properties. This data indicates that 
environmental reservoirs of ruminant prions may be dynamic and the dominant “strain” may change 
over time potentially even leading to the emergence of novel prions. Understanding how TSE strains 
are maintained within populations and how they might have the ability to cause new infections within 
new hosts or after prolonged incubation in environmental reservoirs given the correct selective 
pressures is of importance if we are to minimise the potential for these agents to affect human health. 
1.7. Prion Diseases that Affect Food-Producing Animals 
1.7.1. BSE 
BSE was first discovered in 1986 in UK cattle [26] and led to the BSE epidemic in the UK. One of 
the striking traits of this epidemic was the homogeneity of the BSE agent which led to the conclusion 
that there was only one type of TSE involved. However, the discoveries of BSE cases with features 
that were different from classical BSE have now been reported and are referred to as atypical  
BSE [27–30]. These cases of atypical BSE can be separated into H-BSE so called due to the 
appearance of an unusually high molecular weight of PK-resistant PrPSc as compared to classical  
BSE [27,28,30], and L-BSE so called due to the appearance of PK-resistant PrPSc with a lower 
molecular weight than classical BSE together with a lower proportion of the diglycosylated form [29] 
(Figure 1). L-BSE is also termed bovine amyloidotic spongiform encephalopathy (BASE) as it is 
characterised by the presence of amyloid plaques not observed in classical BSE. Following widespread 
surveillance of small ruminants in the European Union, classical BSE has been found in two cases in 
goats [31,32] but not in sheep [11]. 
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1.7.2. Scrapie 
Classical scrapie in sheep and goats is the prototype TSE and is thought to have existed for 
hundreds of years. An atypical scrapie type in sheep was found in Norway in 1998 and designated 
Nor98, now commonly known as “atypical scrapie" or atypical/Nor98. This differs from classical 
scrapie in several ways, including the neuroanatomical distribution of histopathological lesions and the 
pattern of PrPSc deposits in the brain [33]. In 2002, an obligatory active surveillance programme for 
scrapie in the sheep population submitted for abattoir slaughter was implemented and has resulted in 
an increased diagnosis of classical scrapie across the EU. Additionally, scrapie cases in sheep with the 
newly discovered atypical/Nor98 characteristics have been widely reported [7,34,35].  
In 2007, an atypical/Nor98 scrapie case was found in a Swiss goat [36] the findings of the study 
suggested that cases in goats may have been missed in the past and may continue to be under-
represented due to the routine sampling and analysis of caudal brainstem and cerebellum. The latter is 
a major site of PrPSc deposition in atypical/Nor98 scrapie of sheep but not of goats. Recently a study 
has proposed the co-existence of classical and atypical/Nor98 scrapie types due to the finding of an 
unusual case in Italy in which a sheep showed immunohistochemical and PrPSc features different from 
other atypical/Nor98 cases [37]. 
1.7.3. CWD 
CWD was first identified in captive deer in Colorado in 1967 and has now been described in both 
captive and wild cervid populations across the US, in three Canadian provinces, and in the Republic of 
Korea. Two strains of CWD have been reported in mule deer, Rocky Mountain Elk, white-tailed deer, 
and moose [38,39].  
2. Typing of TSEs in Food-Producing Animals  
Overall, there are a considerable number of TSE types that infect ruminants (Table 1). Whilst 
scrapie, BSE and CWD appear to be mostly constrained to ovines, bovines and caprines respectively, 
the occurrence of natural infections of BSE in multiple mammalian species [32,40–42] indicates the 
potential for these infectious agents to cross species barriers. In addition, there are multiple types of 
each of these TSEs. The ability to define and diagnose individual types of TSE agent is of importance 
to understand the epidemiology, transmission and pathology of these diseases in farmed animals. Prion 
typing also underpins the testing of food products to protect human health by ensuring zoonotic BSE 
prions are not present and by monitoring for the emergence of any novel TSE types. This review will 
report the most up to date advances in the prion typing of natural TSE infections of ruminants. 
2.1. Rodent Bioassay: Wild-Type Mouse Lines 
Prion strains are defined by their distinct and reproducible patterns of replication after serial passage 
in mouse lines. Serial passage experiments in mice of scrapie, BSE and CWD have identified over 20 
distinct TSE strains, with at least 15 different scrapie strains [10], and can allow the discrimination of 
BSE from scrapie. The mouse model is commonly used to demonstrate differences in the incubation 
time (time from inoculation to the onset of clinical symptoms) and brain pathology. This is because, 
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within a particular TSE strain, the genetic background of the mouse model used leads to different 
incubation periods. Thus, consistency in incubation time becomes a good marker for a particular TSE 
strain within a particular genetic background of murine host [43]. In terms of the observed 
neuropathology, different TSE strains can cause marked differences in the severity and distribution of 
the pathological changes within the brain tissue, due to the different neuroanatomical targeting of each 
strain. As a semi-quantitative measure of strain discrimination, the severity of the tissue vacuolation as 
observed by hematoxylin and eosin staining is generally scored from sections of nine grey matter [44] 
and three white matter brain areas [43]. This data is usually plotted to form a lesion profile, reporting 
the severity of lesions being scored against each brain area. The plot that is generated shows 
characteristics of that particular TSE strain within that mouse line.  
A more detailed analysis of the neuropathology and the cell types that are involved can be carried 
out by immunostaining sections of brain for PrPSc within areas of vacuolation. TSE strains demonstrate 
reproducible differences from each other in the extent of this staining [45]. Accumulation of PrPSc at 
different foci within the tissue may be in the form of diffuse deposits within the areas of vacuolation or 
may appear as amyloid plaques [10]. The basis of the differences in the observed neuropathology is 
thought to be due to the differences in the ability of each prion strain conformer to replicate within the 
different cell populations, and this in part may be coincident with subtle differences in the structure of 
PrPC within these sites.  
Without doubt, mouse bioassays have provided a validated method for prion strain discrimination, 
including the analysis of a range of isolates from natural ruminant hosts. The biggest drawback of 
using wild-type mice for the identification of distinct prion strains from natural hosts are the long 
incubation periods and incomplete attack rates that are often associated with the species barrier 
between the inoculums and the murine host on primary passage. 
2.2. Rodent Bioassay: Transgenic Mouse Lines 
To date, around 20% of classical scrapie isolates and all atypical/Nor98 scrapie isolates are unable 
to transmit to the wild type mouse strains that are used for prion typing [46]. Many of the deficiencies 
seen with inbred mouse lines can be resolved by the availability of transgenic lines of mice that either 
express a PrP homologous to the natural host from which the TSE inoculum originated or that express 
much higher levels of rodent PrP. The result of this is an enhancement in the susceptibility to natural 
field isolates and in general greatly reduced incubation times. Transgenic lines are therefore extremely 
useful in the analysis of prions from ruminant host and are contributing to a better estimate of the 
diversity of prion strains/types. Analysis of atypical/Nor98 scrapie in the tg338 mouse line is a good 
example of this. This mouse line over-expresses ovine VRQ PrP (containing amino acids VRQ at 
positions 136, 156 and 171 respectively) and whilst conventional inbred wild type mice are refractory 
to infection by atypical/Nor98 scrapie isolates, tg338 mice are highly sensitive and replicate the PrPSc 
molecular phenotype that is seen in small ruminants with atypical/Nor98 scrapie [47]. In addition, 
Thackray and co-workers detail the use of transgenic mouse lines tg338 and tg59, which express either 
VRQ or ARQ ovine prion respectively, in characterising scrapie isolates that do not transmit to wild 
type mice [48]. Using these two lines they were able to isolate unique scrapie strains at  
secondary passage. 
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Mice transgenic for bovine PrPC have been used to demonstrate the specific features of L-BSE,  
H-BSE and classical BSE (C-BSE). Masujin and co-workers [49] describe the inoculation of bovinised 
mice with either L- or C-BSE. Whilst wild type mice were refractory to infection with L-BSE, the 
transgenic mice developed clinical disease to both L- and C-BSE, with the retention of the same 
biochemical features that distinguish these two prion types in cattle brain. Similarly, H-BSE has been 
used to successfully infect bovinised mice and retained its characteristic molecular phenotype [50]. 
Together, data demonstrate that the three BSE types can be differentiated in bovinised mice [48,49,51], 
providing a method to type BSE material from suspect atypical bovine cases.  
Transmission of CWD prions to wild type mice lines is inefficient. However, mice expressing 
cervid PrPC [52] have high attack rates and low incubation times with cervid derived CWD material 
allowing the analysis of this disease in a rodent model.  
2.3. Bioassay in Other Model Species 
Alternate rodent models have been developed for the monitoring for prion infectivity and prion 
type. In recent years the bank vole has been demonstrated to have a high susceptibility to different 
prion types from a variety of sources [53,54]. The bank vole model is often more sensitive than murine 
models and can have very short incubation times. This model has been demonstrated to be useful in 
cases where a scrapie isolate was not able to infect conventional or transgenic murine lines [54]. The 
brain lesion scoring profiles could again differentiate between two different scrapie isolates and these 
profiles were maintained upon sub-passage of the inoculums. Recently the bank vole has been used to 
isolate a type of CWD exhibiting an extremely low incubation time on secondary passage, with 
incubation periods down to 25-28 days [53]. In a study by Raymond and co-workers [55], multiple 
CWD isolates were inoculated into both transgenic mice and also different species of hamster. The 
study demonstrated that after serial passage in Syrian golden hamsters disease incubation periods of 
CWD isolates could stabilise to either CWD with a short or long incubation period, which was 
indicative of two different CWD strains. More recently, data using a ferret bioassay also demonstrated 
the hallmarks of two different CWD types in material originating from mule deer [56]. Apparent 
differences included incubation time and PrPSc deposition within the CNS and periphery. 
3. Histological and Immunohistochemical Analysis of Tissue from Natural Hosts 
3.1. Histology 
Vacuolation patterns are routinely used in mouse bioassay (often following repeat sub-passage) as a 
diagnostic feature of a prion strain/type. Different prion types can influence lesion profiles in sheep 
scrapie as well, for example when compared to natural classical scrapie, SSBP1 experimental scrapie 
produces relatively few lesions in the medulla oblongata [57,58]. However, vacuolation patterns seen 
in classical sheep scrapie are variable and are influenced by not just prion type but also host PRNP 
genotype [58]. Atypical/Nor98 scrapie produced vacuolation and PrPSc distribution patterns that were 
distinct from those seen with classical scrapie: vacuolation is primarily in the cortex of the cerebellum 
and cerebrum and not the medulla oblongata [33,59]. Amyloidosis is relatively rare in sheep with 
scrapie [60] and is even more rare in cattle BSE [61]. Intraneuronal vacuolation is often observed in 
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cattle BSE but this is not restricted to BSE infections [62]. The lesion profile is consistent for natural 
infections of cattle with classical BSE indicating a single prion type is involved in these  
infections [63,64]. However, there are higher levels of vacuolation and PrPSc accumulation in caudal 
brainstem in clinically affected compared to asymptomatic BSE-infected cattle [65]. 
In goats, BSE and CH1641 (an experimental type of scrapie with a PrPSc molecular phenotype very 
similar to BSE PrPSc; [66]) produce similar vacuolation patterns to the classical scrapie SSBP1 [57,67].  
For CWD infections of deer or elk, again lesions are routinely found in various brain regions 
although within elk the lesions are generally less severe. In deer, pathology is usually found in the 
medulla oblongata, olfactory bulb, cortex and hypothalamus (reviewed in [63]).  
Overall, whilst vacuolation patterns are a diagnostic feature of a prion strain/type in rodent 
bioassays, they have very limited application in the definition of prion types in natural infections due 
to high variability [58,68,69]. 
3.2. Immunohistochemistry 
With BSE in cattle the accumulation of PrPSc is largely consistent between individuals when 
analysing distinct neuroanatomical sites and distinct patterns are observed for different BSE  
types [63,64]. L-BSE (or BASE) produces characteristic amyloid plaques as well as a distinct 
distribution of PrPSc compared to C-BSE: L-BSE PrPSc is present at comparatively lower levels in 
brainstem and higher levels within more rostral sites of the brain such as the olfactory bulb and 
olfactory cortex as well as the hippocampus [29]. At present it is not possible to distinguish C-BSE and 
H-BSE based on PrPSc deposition [65].  
Considerable research effort has gone into using IHC to distinguish experimental BSE infections in 
sheep from other scrapie types. There is no one anatomical location/PrPSc type that can diagnose BSE 
from classical scrapie [70]; however, the defining of PrPSc morphological types, cell-type associations 
as well as levels of PrPSc accumulation across multiple neuroanatomical sites allows the discrimination 
of ovine BSE, CH1641, atypical/Nor98 scrapie and classical scrapie. This technique has been termed 
PrPSc profiling and has been pioneered by Jeffrey and co-workers [66,68,71]. Seven distinct 
morphological types of PrPSc accumulation have been described, each associated with distinct cell 
types: four associated with cell surface or extracellular PrPSc and three with intracellular PrPSc 
(reviewed in [68]). Ovine BSE infections could be distinguished from CH1641 and classical scrapie 
infections with BSE producing relatively high levels of intraneuronal, intramicroglial and neuropil-
associated PrPSc [68,72]. The distinctive BSE profile was not affected by the sheep breed, PRNP 
genotype or route of inoculation of the agent; however, the latter two parameters affected the overall 
levels of PrPSc accumulation [72]. Certain classical scrapie isolates/experimental types can also be 
differentiated via PrPSc profiling due to distinct cell tropisms and PrP processing [71]. However, scrapie 
type and host PRNP genotype affect the PrPSc profile and the extent of PrPSc accumulation [68,71,73]. 
The analysis of both intra- and extracellular PrPSc with a range of antibodies to defined epitopes 
across the length of PrP (PrPSc epitope mapping) is a distinct technique that also displays a high level 
of discrimination [32]. Using this epitope mapping technique, clinical ovine BSE cases and some 
preclinical cases can be distinguished from scrapie by lower levels of intracellular PrPSc containing the 
84-102 amino acid region in dark zone tingible body macrophages (TBMs) of the LRS [74,75] and in 
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neurones and glia in the brain [75]. In addition, intraneuronal levels of PrPSc were consistently higher 
for ovine BSE than scrapie across multiple brain regions when detected with a range of  
antibodies [74]. Interestingly, the exact N-terminal cleavage site for PrPSc for ovine BSE appeared to 
be determined by the cell type with three distinct sites being identified, all of which result in smaller 
PrP fragments compared to classical scrapie PrPSc [75]. The scrapie type CH1641 displays a ‘peptide 
map' for intraglial and intraneuronal PrPSc that is distinct from both classical scrapie and ovine BSE as 
it is truncated even further from the N-terminus than BSE [66]. However, an independent study 
indicated that experimental CH1641 and CH1641-like field isolates may well differ [76].  
With atypical/Nor98 scrapie the pattern of PrPSc accumulation was distinct from classical scrapie with 
increased accumulation in the cerebellar cortex and no accumulation in the medulla oblongata [59]. Such 
cerebellar PrPSc staining was of a diffuse granular type that has not been seen with classical scrapie [59]. 
In addition, for atypical/Nor98 scrapie there was no accumulation of PrPSc in the LRS [33].  
With goat scrapie, very little PrPSc staining was seen with SSBP1 or CH1641 infections, whereas 
goats infected with BSE show clear PrPSc accumulation particularly in the thalamic, hypothalamic 
nuclei and in the basal ganglia [57]. Almost identical peptide mapping was observed for intracellular 
PrPSc when comparing goat and sheep infections, with intraneuronal PrPSc for BSE being truncated 
further from the N-terminus compared to classical scrapie [32]. Interestingly, this peptide mapping 
technique revealed a natural case of goat BSE [32].  
3.3. Diagnostic Applications of Histology and Immunohistochemistry 
For classical BSE, classical scrapie and CWD the presence of spongiform lesions and PrPSc 
accumulation in the medulla oblongata at the level of the obex make this region important for the 
diagnoses of prion disease. The caveat to this is that this region is less involved in pathology in 
atypical/Nor98 diseases and therefore other brain regions require examination, such as the cerebellum 
in sheep [35].  
Whilst vacuolation profiles are consistent for BSE infections in ruminants, other prion diseases of 
these species produce highly variable profiles indicating the very limited application of this technique 
for prion type identification. However, this technique may have an application in distinguishing 
atypical/Nor98 and classical scrapie infections. In contrast, IHC analysis shows great promise in 
defining prion types in the natural host. L-BSE and C-BSE can be distinguished by IHC examination 
as can atypical/Nor98 and classical scrapie infections. The PrPSc profiling and PrPSc epitope mapping 
techniques provide highly discriminatory descriptions of PrPSc phenotypes capable of differentiating 
BSE, CH1641 and classical scrapie infections in small ruminants. It has also been suggested that these 
techniques may even be able to define distinct classical scrapie types in the natural host [69,77]. 
Potential drawbacks to these techniques are that they are relatively laborious, include subjective 
interpretation of PrPSc staining patterns and require the availability of high quality tissue covering an 
extensive range of neuroanatomical sites. For PrPSc profiling, some of these issues have been 
addressed by the simplification of the technique by analysing more restricted neuroanatomical areas 
(within the telencephalon) [69,77]. 
  
Biology 2015, 4 797 
 
 
4. Protease Fragmentation of PrPSc and Glycoform Ratios 
One of the main properties that can differentiate PrPSc from PrPC is the high proteolytic resistance 
of PrPSc. Of course, this trait is not absolute and it is likely that for all prion diseases PrPSc will exist as 
both protease-resistant (PrPSc-res) and protease-sensitive (PrPSc-sen) conformers. At one extreme are 
263K scrapie infection in hamsters and human Gerstmann–Sträussler–Scheinker syndrome P102L 
infection of transgenic 101LL mice, where both infection models accumulate high infectivity titres in 
the absence of PrPSc-res [78]. However, in all other cases, prion diseases produce levels of PrPSc-res 
that are detectable by conventional immunoassays. As such, immunoassay detection of PrPSc-res has 
become the mainstay of prion diagnostics including defining prion types in ruminant diseases. When 
detected in western blots, the pattern of the PrPSc-res fragments can be used to differentiate prion  
types as it is thought that their distinct PrPSc conformers will present distinct cleavage sites to the  
protease (Figure 1).  
4.1. Differentiating Prion Isolates in Small Ruminants 
By far the most common protease used in prion typing is PK, which digests PrPC fully but only 
digests the N-terminal region of PrPSc-res resulting in un-, mono- and di-glycosylated protease 
resistant core. Hill and co-workers reported [79] that BSE in cattle, when passaged in sheep, displayed 
a lower molecular weight unglycosylated PrPSc band compared to classical scrapie. One aspect that 
needs to be taken into account when applying this method is that the metal occupancy of the PrPSc [80] 
and the pH of the sample [81] can influence the apparent molecular weight of the banding pattern. It 
has also been noted that CH1641 scrapie produces a banding pattern indistinguishable from ovine and 
caprine BSE [79,82,83]. This method was further developed by Stack and co-workers [84] who used 
the antibody P4 to detect cleavage products. This antibody binds in the region that is largely removed 
by PK cleavage of ovine BSE PrPSc (and CH1641 PrPSc) but retained during scrapie PrPSc digestion. 
When compared to an antibody binding further C-terminally in the protease resistant core, ratios of P4: 
“core antibody” are much higher for classical scrapie that for BSE or CH1641.  
It was also noted that on western blots the glycoform pattern of the PrPSc-res triplet bands could be 
indicative of prion type, for instance with bovine and ovine BSE displaying a dominant diglycan 
compared to classical scrapie [79]. The robustness of using glycoform patterns for defining prion type 
has been the subject of much debate with some studies reporting that for certain rodent passaged prion 
strains, the glycoform profile of PrPSc can be influenced by host factors such as the brain region and 
PRNP genotype [85,86]. However, other studies have found consistent glycoform profiles across 
different brain regions [83,87,88] and in sheep with distinct PRNP genotypes [87]. Researchers have 
suggested that due to high variation between blots, glycoform profiles need to be derived from 
repeated analysis of samples across multiple blots using photo-imaging techniques to quantify band 
intensities [83,88]. It has also been noted that the glycoform profile will be influenced by the antibody 
used to detect the prion protein, which needs to be taken into account when comparing data between 
studies [83,89]. Whilst glycoform profiling is a useful diagnostic tool, it is difficult to perform and does 
not always show distinction between classical scrapie and BSE, or between CWD and scrapie [90].  
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Screening of small ruminant prion diseases has mainly been designed to distinguish the zoonotic 
agent BSE from the non-zoonotic agents of scrapie. Most studies use a combination of molecular 
weight of PK-resistant PrPSc, the ratio of P4:‘core antibody’ binding and glycoform profiling to search 
for BSE infections. Samples displaying one or more traits of BSE are usually subsequently analysed by 
mouse bioassay for confirmatory prion typing [84,89,91]. Given the experimental designs, it is still 
largely unknown what molecular variations exist for classical scrapie in the natural hosts [82,83,91].  
In addition to PK cleavage, an alternative protease thermolysin can also be applied to distinguish BSE 
from classical scrapie in small ruminants. Digestion resulted in distinct cleavage patterns of PrPSc for 
ovine BSE compared to classical scrapie that was not influenced by host genotype or scrapie type [92]. 
Recently, there have been further developments in the differentiation of BSE from natural scrapie 
with particular emphasis on differentiating BSE from CH1641 which is not possible using any of the 
criteria described above [84]. Pirisinu and co-workers [93] demonstrated that ovine BSE was more 
stable to guanidinium hydrochloride (GndHCl) than classical scrapie or CH1641 scrapie and that 
treatment with 3.5 mol/L GndHCl before digestion in combination with P4/’core antibody’ binding 
ratios allowed the discrimination of both CH1641 and classical scrapie from ovine BSE. Alternatively, 
the probing of a single western blot with differently labelled SAF84 and L42 antibodies revealed a  
so-called dual glycotype aspect at the size of the monoglycosylated band which distinguished CH1641 
from BSE in sheep; as CH1641 had a relatively high SAF84 to L42 binding ratio compared to BSE [8]. 
In addition, a microwell immunofluorometric assay has been developed to differentiate between 
classical scrapie, atypical scrapie, CH1641 scrapie, experimentally infected ovine BSE and naturally 
infected bovine BSE [94]. The assay is based on the capture of PrPSc-res with three distinct antibodies 
that bind to different regions on PrP. Due to distinct PK-cleavage sites for PrPSc from different TSE 
types, all three antibodies capture PrPSc-res from classical scrapie, two bind PrPSc-res from atypical 
scrapie and a different combination of two antibodies bind to PrPSc-res from BSE and CH1641. BSE 
and CH1641 can then be differentiated due to the distinct binding ratios of these two antibodies. 
Endogenous proteolysis also results in PrPSc fragments that may also be indicative of prion type in 
ruminant, such as the so-called C2 fragment in scrapie cases but not in experimental BSE or CH1641 
cases [92] and the diagnostic 14kDa fragment (so called CTF14) that is detected with the antibody 
SAF84 in experimental CH1641 and naturally occurring CH1641-like isolates [95]. 
Atypical/Nor98 scrapie cases were first noted by Bernestad and co-workers [33], this can occur in 
both sheep and goats [36]. Atypical/Nor98 scrapie produces PrPSc-res with a lower protease resistance 
than classical scrapie and PK digestion patterns for atypical/Nor98 scrapie often (but not always, [34]) 
also contain diagnostic fragments between 6.5 and 12 kDa [96]. 
4.2. Differentiating Cattle BSE Types 
The analysis of PK cleavage patterns of PrPSc has led to the description of variants of BSE in cattle. 
Biacabe and co-workers [30] reported higher molecular weight fragments compared to classical BSE, 
and named this atypical type H-BSE. This was shown to be due to cleavage of the atypical PrPSc 
further N-terminally than in classical BSE, resulting in the efficient retention of the 12B2 epitope and 
therefore relatively high levels of binding to this antibody [97]. Casalone and co-workers [29] reported 
a BSE type producing a lower molecular weight PrPSc-res, termed BASE or L-BSE. In addition to the 
Biology 2015, 4 799 
 
 
differences in PK cleavage sites, L-BSE can be distinguished from C-BSE and H-BSE by a distinct 
glycoform pattern [27,28] although as mentioned previously, glycoform profiling of prion types can be 
difficult to perform reproducibly [83,85,86,88]. Also, the H-BSE appears to contain two distinct 
glycoform profiles depending on the antibody used to detect PrP [27] that can be exploited to diagnose 
this type when using the so called dual glycotype aspect for detection [8]. H-BSE also produces a 
unique fragment of 6-10kDa [98]. Whilst the molecular weight and antibody recognition of H-BSE 
PrPSc-res is sufficient to diagnose such infections, the difference in molecular weight between L-BSE 
and C-BSE PrPSc-res is just 0.3kDa for the unglycosylated band and is not suitable for routine prion 
typing [27]. However, Jacobs and co-workers [27] demonstrated that both H-BSE and L- BSE display 
enhanced protease digestion at pH8 relative to pH6.5 compared to C-BSE which may provide a more 
robust biochemical test for distinguishing L-BSE and C-BSE types. 
5. Differential Stability of Prion Types 
The underlying theory that prion characteristics are defined by the conformational make-up of the 
PrPSc molecules led to the development of tests to characterise the stability of these conformers. These 
methods were developed into two complementary assays that quantified the disruption of prion 
conformations with GndHCl [12,99]. The conformation-dependent immunoassay (CDI) analysed the 
exposure of epitopes within PrPSc molecules upon denaturation and the conformational stability assay 
(CSA) measured the loss of PK-resistance of the PrPSc molecules upon denaturation.  
The CDI was developed and applied to rodent passaged strains and could distinguish multiple prion 
strains in hamsters [12]. Despite this obvious promise, the application of the assay for typing of 
ruminant prions has not been pursued. 
The CSA measures the stability of PrPSc-res (Figure 3) and a particular prion type can be defined as the 
[GndHCl]1/2 value: the concentration of GndHCl that results in the denaturation of half of the PrPSc. The 
determination of such values could differentiate some but not all hamster passaged prion strains [100]. 
With respect to ruminant prions, CSA analysis has shown that cattle BSE was less stable than a single 
scrapie isolate but conversely mouse-passaged BSE prion was more stable than passaged scrapie [12]. A 
further study demonstrated that BSE passaged in sheep was more stable than classical and CH1641 ovine 
scrapie [93]. It therefore seems that stability is dictated by both the prion type and host species.  
Pirisinu and co-workers [99] also adapted the CSA assay to analyse the detergent solubility of PrPSc 
upon treatment with a range of GndHCl concentrations, a process termed the conformational solubility 
and stability assay (CSSA). With this CSSA assay, different ovine classical scrapie isolates with a 
range of PRNP genotypes could be differentiated from a similarly diverse set of atypical/Nor98  
scrapie isolates. 
Overall, the analysis of the stability of prion conformers can be monitored through changes in 
epitope accessibility or protease-resistance, and total PrP can be analysed directly or following 
separation of PrPSc from PrPC. Such analyses show significant promise in defining prion types and 
correlating structural properties of the prion with disease pathologies such as the duration of 
asymptomatic or clinical phases of disease. However, relatively little data is available to date on the 
application of such assays to ruminant samples. 
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Figure 3. Conformational stability assay of two scrapie strains (as determined in Tg338 
mice). Two isolates of each strain G338 and Apl338ii were compared by western blotting 
after treatment with increasing concentrations of the denaturant Guanidine hydrochloride 
(GdnHCl). Denatured samples were treated with proteinase K and then western blotted 
using a core antibody. Total PrPSc signal was calculated by densitometry and plotted as a % 
of the PrPSc-res signal after treatment with 0.5M GdnHCl. These two scrapie strains have 
very different sensitivities to GdnHCl, G338 being less stable than apl338. 
6. Cell Culture Methods 
A number of cell lines permissive to prion multiplication have been developed including established 
cell lines, neuronal stem cells, and primary neuronal cells. Whilst initial cell lines were only 
permissive to rodent-adapted prion strains, the rabbit epithelial RK13 cell line expressing an ovine 
PrPC gene was permissive to ovine scrapie and was found to accumulate high levels of PrPSc [101]. 
Since this study, prion replication has been demonstrated in a variety of cell systems. An isolate from 
CWD has been successfully transmitted to a mule deer cell line [102], and cell lines expressing ovine 
PrP (Rov9 and MovS6) have been infected with experimental and natural ovine scrapie agents [103]. 
Cell models of prion infection are comprehensively reviewed by Vilette [104]. 
The standard scrapie cell assay (SSCA) involves the use of susceptible N2a cells which are exposed 
to prion containing samples for 3 days, grown to confluence, split 1:10 three times, then the proportion 
of PrPSc containing cells determined by an ELISA using ELISPOT plates with automated  
counting. [105]. The SSCA has also been combined with the use of the Rov9 and MovS6 cell lines, 
which both express the ovine PrP VRQ allele [103]. The Rov9 cell line could be used to estimate the 
infectious titre of an ovine scrapie brain pool. The SSCA has been further adapted for use in the 
discrimination of rodent-passaged scrapie strains based on the findings that some cell lines show 
preferences for certain strains [105]. However, given that there are only a very limited number of cell 
lines permissive to ruminant prions and even then they are only infected by a limited number of 
isolates, it seems unlikely that this prion typing platform will be applicable to ruminant isolates in the 
near future. 
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7. In Vitro Replication of Prion Types 
A non-radioactive cell free conversion assay that used recombinant mouse PrP as the substrate to 
examine the replication of murine passaged scrapie strains and BSE demonstrated that the conversion 
efficiency differed between some strains [106]. More recently, the protein misfolding cyclic 
amplification (PMCA) methodology has demonstrated distinct replication traits for prion types across 
multiple studies. PMCA is an in vitro prion replication assay that relies on iterative rounds of 
sonication and incubation [107] (Figure 4). The sonication step is thought to break prion aggregates 
into smaller units that can efficiently seed the conversion of PrPC into PrPSc during the incubation 
period. The technique allows the amplification of minute amounts of PrPSc when spiked into normal 
brain homogenate substrate where the prion is amplified over multiple (24–48) cycles of 
sonication/incubation (a round) and the substrate is then replenished by diluting the amplification 
products into fresh substrate. Any number of rounds can then be carried out. When analysing a range 
of rodent passaged scrapie strains or synthetic prions, Gonzales-Montalban and co-workers [108] 
demonstrated that the addition of beads to the PMCA reaction (PMCAb) had distinct effects on 
replication efficiency that was strain dependent. Strains with higher conformational stability displayed 
more enhancement of replication efficiency with the addition of beads compared to strains with lower 
conformational stability. Further analyses demonstrated that the prion strain influenced both the 
growth rate of PrPSc particles and also the total yield of PrPSc produced in the assay [109]. Other 
studies using rodent passaged prion strains have shown that changes in the substrate/cofactor 
availability during the PMCA/PMCAb reactions can also influence the amplification efficiency in a 
strain-specific manner. Such changes have included the use of RNase treated substrate or 
supplementation of substrate with polyA, polyG or DNA [110], as well as the glycosylation state of the 
PrPC substrate [111].  
In terms of the analysis of prions from their ruminant hosts, PMCA has been applied to a range of 
ovine scrapie types as well as ovine passaged BSE. Taema and co-workers [112] demonstrated that 
ovine BSE was amplified within 5 PMCA rounds using either VRQ/VRQ or AHQ/AHQ substrate and 
CH1641 scrapie did not amplify in either substrate. In addition, the use of AHQ/AHQ substrate did not 
support the amplification of any classical or atypical/Nor98 scrapie isolates from sheep with a range of 
PRNP genotypes. These observations have been developed into a sensitive assay using a combination 
of the VRQ/VRQ and AHQ/AHQ brain homogenate substrates [113]. These two substrates encourage 
the amplification of BSE over scrapie and when used in sequential rounds of PMCA have 
demonstrated amplification specificity to BSE, even when BSE is present with a vast excess of 
different scrapie isolates [113,114]. The assay was shown to be far superior to ELISA and western blot 
tests for detecting ovine BSE in the presence of a large excess of scrapie agent [114]. Such an assay 
could be applied to monitor the status of animals for mixed infection where the levels of BSE may be 
very low, and whose detection may be obscured by the presence of scrapie. The ability of PMCA to 
distinguish ovine prion types is further supported by data showing that classical scrapie isolates from 
ARQ/ARQ sheep produced two distinct amplification patterns when amplified in ARQ/ARQ and 
VRQ/VRQ substrates [115]. These amplification patterns were almost always consistent for  
flock-mates indicating the presence of distinct prion types. In addition, classical scrapie type MRI 
could be distinguished from classical scrapie types SSBP1 and Dawson by amplification patterns in 
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these two substrates. Overall, PMCA has shown application in distinguishing ovine prion types by 
analysing amplification efficacy in PrPC substrate with distinct PRNP genotypes.  
 
Figure 4. Protein Misfolding Cyclic Amplification (PMCA) is an in vitro reaction thought 
to reproduce the molecular events of the PrPC to PrPSc conversion that occur in vivo with 
transmissible spongiform encephalopathies (TSE) diseases. Here a PrPC substrate (a 
healthy brain homogenate) is seeded with a PrPSc source, which causes conversion of PrPC 
to further aggregates of PrPSc. These aggregates are fragmented into a number of smaller 
seeds by sonication and the process of prion growth is reinitiated. Over time enough PrPSc 
can be produced to be detected by western blot. Quaking induced conversion (Quic) is an 
alternative in vitro assay that is also based on the seeding ability of PrPSc. A PrPSc seed is 
used to convert a recombinant PrPC substrate into an “amyloid” form. These large 
aggregates are fragmented into smaller seeds by vigorous shaking followed by further  
re-seeding and growth. Quic reactions are generally monitored by Thioflavin T 
fluorescence over time but the products can also be measured by western blot. 
Together, the data supports the hypothesis that a range of substrate/co-factor conditions in tandem 
with a range of amplification conditions could provide a panel of defined PMCA conditions capable of 
defining prion types in the natural host; effectively producing an “amplification profile” for each 
ruminant prion type.  
Recently, the use of recombinant bank vole PrP as a universal substrate for a similar in vitro 
replication assay known as quaking induced conversion or “Quic” has been described [116] (Figure 4). 
Quic differs from PMCA in that fibrils of recombinant prion are generated during cycles of incubation 
followed by shaking which is thought to break growing fibrils and form the new nucleation sites for 
fibril formation. The products of the reaction are formed from the seeding effect of prion containing 
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material; however unlike PMCA the products of this reaction are non-infectious. The authors 
demonstrate some specific differences in the PK digestion profiles on western blots of Quic reaction 
products that were seeded by different ruminant prion types, demonstrating that in vitro amplification 
and prion typing of unknown samples may be possible using this rapid and sensitive technique. 
8. Conclusions and Future Perspectives 
Whilst the cases of BSE in ruminants is now very low and the associated concern for the 
contamination of the human food chain with the zoonotic BSE agent has eased, there are still concerns 
surrounding the exposure of humans to prions from food-producing animals. The more recent 
description of atypical/Nor98 scrapie in goats/sheep and atypical bovine BSE as well as the discovery 
of two distinct types of CWD all raise the possibility that further types of prions are circulating in 
ruminants that are not detected and/or defined by current assay methods. An additional concern is that 
novel types may emerge in these animals. One diagnostic challenge in prion biology is to develop and 
apply prion typing tests to fully elucidate the range of existing prion types in ruminants and to monitor 
for the emergence of novel types. This is a significant challenge as it is unknown what molecular and 
pathological differences any novel type will have compared to those already described. Therefore, 
assays that have a wide range of distinct measurements that describe a PrPSc type or in vivo pathology 
will be best suited for diagnosing new prion types.  
There have been significant advances in recent years in in vitro prion typing assays. The 
development of PrPSc profiling and PrPSc epitope mapping provide IHC methods that can differentiate 
classical, atypical/Nor98 and CH1641 scrapie from BSE in sheep and has the potential to further 
discriminate between classical scrapie types. The methods examine multiple anatomically distinct 
brain regions and cellular prion locations and/or map multiple epitopes of PrPSc. The methods therefore 
have a wide range of possible test outcomes that are examined and have great diagnostic application. 
The drawbacks of these methods are that they are labour intensive and require extensive good quality 
brain material. Prion typing tests are almost certainly going to be most applicable to post-mortem 
derived tissues from routine sampling sites in animals confirmed as having a prion disease. Therefore, 
the application of these IHC methods using routine surveillance samples to test for novel or existing 
types is perhaps limited. The examination of proteolytic fragments of PrPSc by western blotting has 
formed the mainstay of high throughput prion typing assays for ruminants. Recent advances using 
multiple antibody probes for single western blots along with the partial denaturation of samples prior 
to proteolysis have improved the diagnostic capability of such tests. However, these assays have each 
been specifically designed to differentiate defined existing prion types by looking for a specific 
fragmentation pattern and therefore may be limited in their application to detecting novel prion types. 
In contrast, the CSA measures the stability of a prion type over a range of denaturation conditions and 
therefore may well define novel types with distinct stabilities. It could be envisaged that the use of 
multiple denaturation conditions within CSA combined with epitope mapping of the resulting PrPSc 
fragments by western blot could provide a range of test outputs that measure the conformation of PrPSc 
to define types. A limitation of PrPSc analysis in all of these methods may be that PrPSc can display 
variation in its neuroanatomical location dictated by the prion type pathology and sufficient PrPSc may 
not be present at the routine sampling sites to allow analysis by these methods. A methodology that 
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could detect prion types at very low concentration would therefore be advantageous. PMCA may 
provide such a method. It has been reported that PMCA usually maintains the PrPSc molecular profile 
of the seed and is exquisitely sensitive in detecting PrPSc. A combination of PMCA amplification 
followed by analysis of the PrPSc product by an assay such as CSA may allow a robust prion typing 
assay to detect novel types even when PrPSc is present at low levels in the tissue sample. Alternatively, 
PMCA methods have now also been directly applied to prion typing in ruminants demonstrating that 
different prion types display different replication efficiencies under defined conditions. The data 
supports the hypothesis that a range of substrate/co-factor conditions in tandem with a range of 
amplification conditions could provide a panel of defined PMCA conditions capable of defining prion 
types from the natural host; effectively producing an ‘amplification profile’ for each type.  
For all in vitro prion typing assays the definition of a novel prion type would need to be assessed as 
being representative of an inheritable in vivo strain phenotype rather than of a quasispecies that was 
selected/identified during the in vitro analyses. Therefore, any novel type would require analysis 
within rodent bioassay to define a novel and consistent pathology that is stable upon sub-passage and 
can therefore be described as a novel prion strain. The recent advent of transgenic murine models and a 
range of rodent host species have extended the use of rodent bioassay to a relatively wide range of 
natural ruminant isolates making this a much more realistic possibility. 
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